A cancer survivor shares what happens when a routine surveillance scan brings an unexpected finding — and how she navigated ...
For Scerbo, the answer traces back to a single patient, a boy she met during her pediatric rotation who was being treated for ...
Talquetamab combined with daratumumab, with or without pomalidomide, meaningfully prolonged PFS versus daratumumab/pomalidomide/dexamethasone in relapsed/refractory ...
In this episode of The Moonlight Shift, Joshua Richter, MD, associate professor of medicine in The Tisch Cancer Institute, ...
In an interview with CURE, oncology nurse Jill Winther, who has spent 35 years caring for patients with cancer, discussed why ...
When a child is diagnosed with cancer, the immediate priority for families is survival. But according to Dr. Jessica Scerbo, ...
Recurrent peer loss in metastatic breast cancer can manifest as cumulative grief, distinct from single-event bereavement and ...
Five-year KEYNOTE-942 data show a personalized cancer vaccine plus Keytruda reduced recurrence risk in patients with ...
CURE spoke with breast cancer survivor and advocate Kiana Wooten about the items and rituals that helped her through ...
New findings presented at ASCO 2026 show that a CAR-T cell therapy called Breyanzi (lisocabtagene maraleucel) is producing ...
The message Tolaney wants patients with newly diagnosed metastatic TNBC to take away from these findings is one of clarity ...
Erythroid responses favored luspatercept: 76.4% achieved ≥12-week transfusion independence, 25.3% remained transfusion-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results